The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Drug Interactions
Both CYP3A4 and CYP2D6 are responsible for Abilify Oral Solution metabolism. Agents that induce CYP3A4 (eg, carbamazepine) could cause an increase in Abilify Oral Solution clearance and lower blood levels. Inhibitors of CYP3A4 (eg, ketoconazole) or CYP2D6 (eg, quinidine, fluoxetine or paroxetine) can inhibit Abilify Oral Solution elimination and cause increased blood levels.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
